Angiogenic signature of multiple myeloma determined by gene expression profiling

被引：0

作者：

Hose, Dirk ^{[1
,6
]}

Moreaux, Jerome ^{[2
]}

Meissner, Tobias ^{[1
,3
]}

Rossi, Jean-Francois ^{[2
]}

Benner, Axel ^{[3
]}

Mahtouk, Karene ^{[2
]}

Seckinger, Anja ^{[1
]}

Heiss, Christiane ^{[3
]}

Hundemer, Michael ^{[1
]}

Reme, Thierry ^{[2
]}

Hillengass, Jens ^{[1
]}

Herde, Katja ^{[5
]}

Bertsch, Uta

DeVos, John ^{[2
]}

Wenisch, Sabine

Pantesco, Veronique ^{[2
]}

Jauch, Anna ^{[4
]}

Jourdan, Eric ^{[2
]}

Goldschmidt, Hartmut ^{[6
]}

Klein, Bernard

Moehler, Thomas ^{[6
]}

机构：

[1] Univ Hosp Heidelberg, Heidelberg, Germany

[2] CHU Montpellier, INSERM, U475, Montpellier, France

[3] German Canc Res Ctr, D-6900 Heidelberg, Germany

[4] Univ Hosp Heidelberg, Inst Human Genet, Heidelberg, Germany

[5] Expt Surg Lab, Giessen, Germany

[6] Natl Ctr Tumor Dis, Heidelberg, Germany

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2484

引用

页码：732A / 733A

页数：2

共 50 条

[31] Toward the molecular classification of myeloma: Gene expression profiling in the diagnosis, prognosis, and treatment of multiple myeloma.
Zhan, F
Bumm, K
Tian, E
Xu, H
Zangari, M
Desikan, R
Badros, A
Morris, C
Toor, A
Anaissie, E
Tricot, G
Barlogie, B
Shaughnessy, J
LEUKEMIA, 2001, 15 (03) : 493 - 493
[32] A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
C Botta
M T Di Martino
D Ciliberto
M Cucè
P Correale
M Rossi
P Tagliaferri
P Tassone
Blood Cancer Journal, 2016, 6 : e511 - e511
[33] A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma
A K Mitra
T Harding
U K Mukherjee
J S Jang
Y Li
R HongZheng
J Jen
P Sonneveld
S Kumar
W M Kuehl
V Rajkumar
B Van Ness
Blood Cancer Journal, 2017, 7 : e581 - e581
[34] A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
Botta, C.
Di Martino, M. T.
Ciliberto, D.
Cuce, M.
Correale, P.
Rossi, M.
Tagliaferri, P.
Tassone, P.
BLOOD CANCER JOURNAL, 2016, 6 : e511 - e511
[35] A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma
Mitra, A. K.
Harding, T.
Mukherjee, U. K.
Jang, J. S.
Li, Y.
HongZheng, R.
Jen, J.
Sonneveld, P.
Kumar, S.
Kuehl, W. M.
Rajkumar, V.
Van Ness, B.
BLOOD CANCER JOURNAL, 2017, 7 : e581 - e581
[36] Gene expression profiling illuminates myeloma biology
Steward, AK
BLOOD, 2003, 101 (12) : 4650 - 4650
[37] Construction of immune-related gene pairs signature to predict the overall survival of multiple myeloma patients based on whole bone marrow gene expression profiling
Jafari-Raddani, Farideh
Davoodi-Moghaddam, Zeinab
Bashash, Davood
MOLECULAR GENETICS AND GENOMICS, 2024, 299 (01)
[38] PROTEASOME INHIBITOR TREATMENT RESPONSE CAN BE PREDICTED BY GENE EXPRESSION PROFILING IN MULTIPLE MYELOMA
Van Vliet, M. H.
Kuiper, R.
Broijl, A.
Van Duin, M.
de Best, L.
van Beers, E. H.
Sonneveld, P.
HAEMATOLOGICA, 2014, 99 : 494 - 495
[39] Gene Expression Profiling Is a Strong Predictor of Clinical Outcomes in Newly Diagnosed Multiple Myeloma
Claussen, Catherine M.
Chuang, Tammy
Chaudhry, Maria
Lee, Hans C.
Patel, Krina K.
Bashir, Qaiser
Parmar, Simrit
Ahmed, Sairah
Mehta, Rohtesh S.
Thomas, Sheeba K.
Richards, Tiffany A.
Nieto, Yago
Shpall, Elizabeth J.
Qazilbash, Muzaffar H.
Amini, Behrang
Davis, Richard E.
Neelapu, Sattva S.
Weber, Donna M.
Orlowski, Robert Z.
Feng, Lei
Manasanch, Elisabet E.
BLOOD, 2017, 130
[40] High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling
Van Vliet, Martin H.
Chen, Yan-Ting
Van Beers, Erik H.
Kuiper, Rowan
Valent, Erik T.
Spaan, Marieke
Terragna, Carolina
Zamagni, Elena
Cavo, Michele
Oliva, Stefania
Larocca, Alessandra
Haferlach, Torsten
Chng, Wee-Joo
Waage, Anders
Duin, M.
Sonneveld, Pieter
BLOOD, 2020, 136

← 1 2 3 4 5 →